摘要
目的 探讨Encor微创旋切系统联合超声BI-RADS分级在乳腺病灶诊治中的应用价值.方法 对笔者所在医院2009年9~2010年12月行乳腺病灶Encor微创手术切除的82例患者的乳腺超声BI-RADS分级和术后病理资料进行回顾分析.结果 Encor微创手术操作成功率达100%.82例患者中乳腺癌3例,纤维腺瘤71例,导管内乳头状瘤3例,乳腺腺病5例.超声BI-RADS分级2级10例,3级有48例,4级22例,5级2例.BI-RADS分级2~3级病例无乳腺癌;BI-RADS分级4级有2例乳腺癌,占4级病例的(2/22);BI-RADS分级5级有1例乳腺癌,占4级病例的(1/2).术后发生局部血肿3例,皮下淤血10例,无感染及其他并发症,皮肤切口无明显切口瘢痕.乳腺良性肿瘤3~6个月超声复查均未见复发.结论 Encor微创旋切系统对乳腺病灶切除活检效果良好,联合超声BI-RADS分级能准确评价乳腺病灶的性质.
Objective To investigate the value of Encor Biopsy System and Breast Imaging Reporting and Data Sys- tem - ultrasound( B] - RADS - US) assessment in diagnosis of breast lesion. Methods Clinieal data and BI - RADS - US categories of 82 patients with breast lesion that received Eneor biopsy in our hospital from September 2009 to December 2010 were analyzed retrospectively. Results All the breast lesion of patients were successfully resected by Eneor Biopsy System. Of all 82 eases, 3 cases were breast eaneer, 71 eases were fibroadenoma, 3 eases were intraductal papilloma, 5 eases were fibro- adenosis. According to BI - RADS - US, 10 eases were BI - RADS 2, 48 cases were BI - RADS 3, 22 eases were BI - RADS 4, 2 cases were BI - RADS 5. There was no breast cancer in BI - RADS 2 and BI - RADS 3.2 casesof BI - RADS 4 (9. 1% ) and lease of BI - RADS 5(50. 0% ) were confirmed to be breast cancer. Only 3 cases had the complication of hematoma and l0 cases had skin eccbymosis. No recurrence was found in patients with benign lesion after a follow - up of 3 to 6 months. Conclusion Ultrasound Guided Encor Biopsy System can be applied effectively for the excision of breast lesion and BI - RADS - US can give useful information for the diagnosis of breast lesion.
出处
《中国医学创新》
CAS
2011年第11期111-112,共2页
Medical Innovation of China
关键词
乳腺肿瘤
Encor
微创手术
Breast neoplasm
Encor
Minimally invasive surgery
Uhrasonography